World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 3 May 2021
Main ID:  ISRCTN10718603
Date of registration: 24/11/2017
Prospective Registration: No
Primary sponsor: Forsknings- og Innovationsstyrelsen (National Research Council)
Public title: The effect of EMG biofeedback: a randomized controlled clinical trial in patients with shoulder pain
Scientific title: The effect of eight weeks of training with and without EMG biofeedback, on pain and muscle function in patients with shoulder impingement: a randomized controlled clinical trial
Date of first enrolment: 01/09/2010
Target sample size: 40
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN10718603
Study type:  Interventional
Study design:  Single-centre randomised controlled trial (Treatment)  
Phase:  Not Applicable
Countries of recruitment
Denmark
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Karen    Søgaard
Address:  Dep of Sport Sciences and Clinical Biomechanics. Dep of Clinical Research University of Southern Denmark, Odense Campusvej 55 5230 Odense Denmark
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
1. At least 30 days with pain/discomfort in the shoulder/neck region within the last year
2. At least two or more positive impingement tests based on the Jobe, Neer; Hawkins and Apprehensions tests
3. 18-65 years old

Exclusion criteria:
1. Equal or more than 8 in pain/discomfort - measured with Numeric Rating Scale from 0-10 (NRS) - throughout the last 24 hours (on test day)
2. Had more than three regions with pain, for at least 30 days during the last 12 months
3. Had a history of severe shoulder-neck pathology/trauma and/or orthopaedic surgery and/or received anti-inflammatory injections within the last 3 months
4. If they were pregnant (EMG precaution)
5. Any documented life threatening diseases
6. Cardiovascular diseases
7. Rheumatoid arthritis
8. Generalized pain
9. Adverse psychosocial conditions
10. Signs for cervical radiculopathy, i.e. Spurling A test, Involved Cervical Rotation test (less than 60?), Neck Distraction test


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Subacromial impingement syndrome (SIS)
Musculoskeletal Diseases
Impingement syndrome of shoulder
Intervention(s)

The intervention program was divided into two periods. The first period was a three-week phase with instruction in different exercises with focus on LT and SA activation. The purpose was to (re)activate the muscles and thereby increase the subjects’ awareness of those muscles’ position and function. The purpose of the second period (a five-week phase) was to transfer the awareness gained through the first phase into the performance of more functionally complicated exercises. Here, coactivation of the LT and SA in dynamic movements was emphasised in order to master exercises and succeed to the next. Standardised progression regimes according to the subjects’ individual pain levels were developed and followed in both first and second period. The subjects were supervised once a week by the same physiotherapist and instructed how to progress and to do the exercises with 2x10 repetitions once a day during the eight weeks of intervention. Also, stretching exercises and ergonomic instructions were given.

All participants in this study received the same exercises. The only difference between the interventions applied to the intervention and control group was the provision of online visual feedback of muscle activity, shown horizontally (from left to right) on a monitor (biofeedback) visible for both the subject and instructing physiotherapist in the intervention group. The no-EMG control group only received instructions from the physiotherapist based on quality of exercise and if needed, manual/tactile corrections.
Primary Outcome(s)

Self-reported pain assessed using a numeric rating scale (NRS) as part of a questionnaire filled out before commencing physical testing at baseline and follow-up (week 0 and 8):
1. “Pain now” measured on NRS (0-10) at baseline and follow-up testing
2. “Pain within the last 24 hours” measured on NRS (0-9) at baseline and follow-up testing
3. “Pain within the last 7 days” measured on NRS (0-9) at baseline and follow-up testing
Furthermore, the subjects were asked to register their daily pain level in a diary throughout the eight weeks of home exercise. This diary was used to measure the daily pain development (NRS 0-10) and then to measure compliance, as the subjects would register the execution of their home exercises.
Secondary Outcome(s)

1. Self-reported shoulder-scores obtained from questionnaires at baseline and follow-up:
1.1. Disability of the Arm, Shoulder and Hand questionnaire (DASH)
1.2. The Oxford Shoulder Score (OSS)
2. Muscle activity measured by surface electromyography (sEMG) signals from three muscles: upper trapezius (UT), lower trapezius (LT) and serratus anterior (SA). The measurements were carried out according to a standardized experimental procedure, containing a voluntary movement task (described in experimental procedure). During arm elevation, mean relative activity (percentage of maximal voluntary electric activity, %MVE) was measured and muscle activation ratios between the muscles (UT/LT and UT/SA) were calculated. Measured at baseline and follow-up.
Secondary ID(s)
Danish Association of Rheumatism R62 A985
Source(s) of Monetary Support
Syddansk Universitet
Secondary Sponsor(s)
Gigtforeningen (Danish Association of Rheumatism)
Danish Ministry of Higher Education and Science
Region Syddanmark
Ethics review
Status:
Approval date:
Contact:
Regional Ethical Committee of Southern Denmark, 09/11/2009, Project ID: S-20090090
Results
Results available: Yes
Date Posted:
Date Completed: 11/07/2012
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history